Which vaccines will RFK end recommendations for?
$1,227,126 Vol.
OUTCOME
% CHANCE
COVID-19
$519,986 Vol.
25%
COVID-19
$519,986 Vol.
25%
Measles Mumps and Rubella
$257,175 Vol.
14%
Measles Mumps and Rubella
$257,175 Vol.
14%
HPV
$296,935 Vol.
13%
HPV
$296,935 Vol.
13%
Influenza
$21,022 Vol.
12%
Influenza
$21,022 Vol.
12%
Hepatitis B
$122,715 Vol.
9%
Hepatitis B
$122,715 Vol.
9%
Polio
$9,293 Vol.
5%
Polio
$9,293 Vol.
5%
Rules
This market will resolve to "Yes" if the CDC has completely ended its recommendation for the listed vaccine, meaning it no longer recommends it for any category of individuals by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”.
A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution.
The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution.
The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
Volume
$1,227,126
End Date
Dec 31, 2025
Resolver
0x6A9D222616...$1,227,126 Vol.
Which vaccines will RFK end recommendations for?
OUTCOME
% CHANCE
COVID-19
$519,986 Vol.
Measles Mumps and Rubella
$257,175 Vol.
HPV
$296,935 Vol.
Influenza
$21,022 Vol.
Hepatitis B
$122,715 Vol.
Polio
$9,293 Vol.
About
Volume
$1,227,126
End Date
Dec 31, 2025
Resolver
0x6A9D222616...
Beware of external links.
Beware of external links.